PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
15-Jul-2020 Destiny Pharma notes launch of $1 billion pharma-backed fund to develop new anti-infectives Destiny Pharma plc
15-Jul-2020 Trading Update Allergy Therapeutics plc
15-Jul-2020 Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer Byondis B.V.
15-Jul-2020 Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner BaseLaunch
15-Jul-2020 Alliance for Regenerative Medicine Responds to EU Pharmaceutical Roadmap Alliance for Regenerative Medicine
15-Jul-2020 J&J's price reduction of lifesaving TB drug is an important step; governments must scale up use Johnson & Johnson
15-Jul-2020 Half of British public ‘scared’ of going to hospital due to COVID-19 risk and time-wasting Incisive Health
08-Jul-2020 Novavax receives $1.6bn from OWS with ambitious vaccine delivery target, says GlobalData GlobalData
08-Jul-2020 PTC Therapeutics Announces First Patient Dosed in Phase 1 Trial for PTC857 PTC Therapeutics, Inc
08-Jul-2020 Alan Kennedy Wins Lifetime Achievement Award at the Asia-Pacific Bioprocessing Excellence Awards Team Poseidon Ltd
08-Jul-2020 Rigenerand commences 3D bioreactor development for cGMP extracellular vesicle exosomes (EV) production Rigenerand SRL
08-Jul-2020 PureTech Founded Entity Sonde Health Launches New Voice-Enabled Health Screening Tool to Potentially Help Employers Return to Work During the Global Pandemic PureTech Health plc
08-Jul-2020 Rigenerand commences 3D bioreactor development for cGMP extracellular vesicle exosomes (EV) production Rigenerand
08-Jul-2020 Next-generation Triple Antibody Test for COVID-19, developed by British company Attomarker, has been authorised by the MHRA following positive trial results Attomarker Ltd
08-Jul-2020 QUAY EXPERTISE SUPPORTS NEW DRUG FOR TACTIC-E COVID-19 TRIAL Quay Pharma
08-Jul-2020 Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe Aetion
08-Jul-2020 EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer AstraZeneca
08-Jul-2020 National strategy for digital scientific discovery urgently required to tackle global crises The Royal Society of Chemistry
08-Jul-2020 EPO launches new platform to help researchers in the fight against coronavirus The European Patent Office (EPO)
08-Jul-2020 Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer AstraZeneca PLC